Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs SignalHF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
SignalHF
by Implicity

AI Verdict

These tools are adjacent in the healthcare AI landscape, both leveraging AI for predictive insights in cardiology. Acumen HPI focuses on real-time prediction of acute hypotensive events in critical care and surgical settings, utilizing dedicated hemodynamic monitoring. In contrast, SignalHF predicts longer-term heart failure hospitalizations by analyzing data from cardiac implantable electronic devices for chronic patient management.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary concern is real-time, proactive management of hemodynamic instability and the prevention of acute hypotensive events in surgical or critical care settings. This tool is ideal for anesthesiologists and critical care teams needing to predict hypotension up to 15 minutes in advance and gain immediate insights into underlying hemodynamic parameters like preload, afterload, and contractility.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose SignalHF if…

Choose SignalHF if you manage a cohort of heart failure patients with cardiac implantable electronic devices (CIEDs) and aim to reduce hospitalizations through proactive, personalized outpatient care. This AI algorithm is best suited for cardiology teams seeking to predict heart failure hospitalizations within 30 days by analyzing CIED data, enabling early intervention and optimization of treatment plans.

View SignalHF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform SignalHF
Pricing Unknown Contact for pricing
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) SaaS
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI's direct integration with the Edwards Lifesciences HemoSphere platform and its real-time visual insights, such as Smart Trend and Relationship View, make it highly usable within the immediate, fast-paced acute care environment. Its design focuses on providing actionable information seamlessly within existing clinical workflows at the bedside.

Clinical Value

Tie

Both tools offer significant, FDA-cleared clinical value by addressing critical patient outcomes in different care settings. Acumen HPI provides a crucial window for intervention in acute hypotension, while SignalHF enables proactive management to prevent heart failure hospitalizations. The impact of preventing an acute, life-threatening event versus preventing a chronic disease exacerbation is equally profound.

Pricing & Value

Tie

Neither tool provides transparent pricing information, making a direct comparison of their cost-effectiveness or overall value proposition impossible. Both are enterprise-level solutions where pricing is typically negotiated based on deployment scope and features, thus a tie is appropriate.

Enterprise Readiness

SignalHF

SignalHF's SaaS deployment model and explicit manufacturer-agnostic compatibility with various Cardiac Implantable Electronic Devices (CIEDs) offer greater flexibility and ease of integration into diverse hospital IT ecosystems. The inclusion of a Business Associate Agreement (BAA) further solidifies its readiness for enterprise-level data privacy and security requirements.

Innovation

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI's innovation extends beyond mere prediction by offering real-time insights into the underlying physiological drivers of hypotension, such as preload, afterload, and contractility. This deeper diagnostic guidance allows clinicians to implement more targeted and effective interventions in an acute setting, representing a significant advancement in real-time hemodynamic management.

Support & Docs

Tie

The provided information does not contain specific details regarding the support and documentation offerings for either tool. As both are from reputable companies in the healthcare technology space, it is reasonable to assume they both provide standard enterprise-level support and documentation, leading to a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform SignalHF
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform SignalHF
Company Edwards Lifesciences Implicity
Tagline Predicting and managing hypotension before it occurs. Revolutionizing Heart Failure Care with Predictive AI
Primary Prediction Focus Hypotensive events Heart failure hospitalizations
Prediction Timeframe Up to 15 minutes in advance Within 30 days
Data Sources/Compatibility Dedicated sensors (Acumen IQ cuff or sensor); Non-invasive (Acumen IQ cuff) and minimally-invasive (Acumen IQ sensor) options Manufacturer-agnostic compatibility with various CIEDs (pacemakers, ICDs, CRTs); Analyzes physiological data, demographics, lead measurements, episodes, and therapies
Key Insights/Alerts Provided HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, Smart Trend screen, Relationship View screen (preload, afterload, contractility insights) Generates automatic alerts for care teams based on risk scores, AI-driven alert management to filter and highlight relevant events

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and SignalHF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI is designed for acute care, integrating with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform to provide real-time, continuous hemodynamic monitoring and alerts for intraoperative hypotension. SignalHF, conversely, is for chronic heart failure management, analyzing data from various cardiac implantable electronic devices to predict hospitalizations within 30 days, enabling proactive outpatient care.
Acumen HPI is integrated with the Edwards Lifesciences HemoSphere platform, which records vitals and the predictive index every 20 seconds, and data can be downloaded for analysis. SignalHF is a SaaS platform that centralizes cardiac implantable device data, generates automatic alerts for care teams based on risk scores, and offers smart workflow automation including automated reporting.
Acumen HPI software demonstrated high accuracy in predicting intraoperative hypotension, with a sensitivity of 90% and specificity of 89% at 10 minutes before an event, and an AUC of 0.95. SignalHF for ICD/CRT-Ds demonstrated a sensitivity of 60% and for PM/CRT-Ps, a sensitivity of 46% for detecting heart failure hospitalizations.
The provided information does not explicitly detail the learning curve or time-to-value for either tool. However, Acumen HPI offers clinical education resources to support users, and SignalHF aims to enable early intervention and personalized care plans, suggesting a focus on rapid integration into clinical practice.
Acumen HPI provides continuous hemodynamic monitoring and smart alerts, with data downloadable from the monitor for retrospective analysis, which can support auditing. SignalHF generates automatic alerts and offers AI-driven alert management to filter and highlight relevant events, with a unified platform for centralizing cardiac implantable device data, which could facilitate multi-site management.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or SignalHF

Backers

Who funded each tool's parent company.

SignalHF

AI Tool Finder
AI-powered search. Results may not be comprehensive.